FF
BIIB icon

Friedenthal Financial’s Biogen BIIB Stock Holding History

Friedenthal Financial’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,930
Closed -$1.09M – 262
2026
Q1 		$1.09M Buy
+5,930
New +$1.09M 0.55% 36

Other funds holding BIIB

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

Friedenthal Financial's BIIB Position: Q2 2026 in Review

Friedenthal Financial sold out of Biogen (BIIB) in Q2 2026, closing a stake of 5,930 shares — an estimated $1.09M sold.

Friedenthal Financial first reported a position in BIIB in Q1 2026 and held it in 1 quarter. The position peaked at $1.09M in Q1 2026. 185 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Friedenthal Financial reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
  • Friedenthal Financial sold 5,930 Biogen shares in Q2 2026, an estimated $1.09M.
  • Friedenthal Financial first reported a position in Biogen in Q1 2026 and held it in 1 quarter.
  • Friedenthal Financial's Biogen position peaked at $1.09M in Q1 2026.
  • 185 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Friedenthal Financial's 13F filing for Q2 2026, filed 13 Jul 2026.